MedPath

Study of the effectiveness of Bilva ointment on burn wound outcomes of patients admitted

Not Applicable
Conditions
burn wound outcomes of patients admitted.
Corrosion of second degree of shoulder and upper limb, except wrist and hand
Registration Number
IRCT20160424027561N11
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
33
Inclusion Criteria

Patients with 20% or less burns of second degree
The location of the burn in the symetric extremities with the same depth
Patients who do not have any underlying disease such as diabetes mellitus, allergic skin diseases, malignancy, AIDS, hypertension, and cytotoxic drugs.
It is not more than 2 hours from the time of burning up to the time of entry into the research
The patient's wound is not impregnated with contaminants
The patient did not use any substance other than drinking water on the wound before the sample entered the study
Before entering the study, the patient is not infected with different parts of the body
The patient is able to answer questions.

Exclusion Criteria

The cause of the patient's burn is chemical or electrical.
Patients who have inhaling injuries

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Burn wound healing score. Timepoint: Day one, seventh, fourteenth, twenty eight, one month later, two months later, three months later. Method of measurement: Bates-Jensen wound assessment tool.;Pain. Timepoint: Day one, seventh, fourteenth, twenty eight, one month later, two months later, three months later. Method of measurement: Visual analogue scale (VAS).;Itching. Timepoint: Day one, seventh, fourteenth, twenty eight, one month later, two months later, three months later. Method of measurement: itching Visual analogue scale (VAS).;Infection. Timepoint: Day one, seventh, fourteenth, twenty eight, one month later, two months later, three months later. Method of measurement: questionnaire.;Hypertrophy of scar. Timepoint: one month later, two months later, three months later. Method of measurement: Vancouver questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath